Â鶹´«Ã½

The selected channel has been deleted from your list of favorites.

Our Â鶹´«Ã½ on Â鶹´«Ã½

Roswell Park Experts to Showcase Groundbreaking Hematology Research at 66th ASH Annual Meeting

Roswell Park experts representing various specialties will highlight innovative research and advancements in hematology and hematologic cancers at the 66th annual meeting of the American Society of Hematology (ASH), to be held December 7-10 in San...
19-Nov-2024 3:35 PM EST Add to Favorites

Roswell Park Clinical Trial Points Toward Promising New Therapy for Most Aggressive Type of Breast Cancer

A new treatment approach developed at Roswell Park Comprehensive Cancer Center has shown promising results in a phase 1 clinical trial for patients with triple-negative breast cancer (TNBC), the most aggressive type of breast cancer. Results of the...
18-Nov-2024 9:50 AM EST Add to Favorites

Â鶹´«Ã½: 672137c6d7d7f_Research-Dr.Gudkov2.12.21-44.jpg

New Computational Method Links One Mammal’s Striking Longevity and Resistance to Cancer With ‘Dark Genome’

The Roswell Park team has developed a new method to measure mutation loads across species, revealing the role of the "dark genome" — ancient, virus-like genes that affect cellular function. The findings support further exploration of antiviral...
29-Oct-2024 4:00 PM EDT Add to Favorites

Â鶹´«Ã½: kara-kelly-landscape.jpg

Breakthrough Clinical Trial Reveals Better Treatment for Advanced Classic Hodgkin Lymphoma

Updated results from a phase 3 clinical trial are expected to change the way advanced stage classic Hodgkin lymphoma (cHL) is treated. Details appear in a study published today in The New England Journal of Medicine. Drs. Kara Kelly of Roswell Park...
16-Oct-2024 8:45 PM EDT Add to Favorites

Â鶹´«Ã½: 66fb36c4cbecb_20200723Dr.WangLab-070.jpg

Study Highlights Promising New Treatment Option for Patients With Treatment-Resistant Acute Myeloid Leukemia

The Clinical Leukemia Service at Roswell Park Comprehensive Cancer Center helped lead the first clinical trial of the experimental oral drug ziftomenib in patients with acute myeloid leukemia (AML).
30-Sep-2024 7:05 PM EDT Add to Favorites

Â鶹´«Ã½: hahn_theresa_landscape.jpg

Disparities Narrowing Among Patients Undergoing Blood Stem Cell Transplant, Roswell Park Study Reveals

Open Disparities Narrowing Among Patients Undergoing Blood Stem Cell Transplant, Roswell Park Study Reveals configuration options Historically, some patients with blood cancers have been less likely than others to receive stem cell transplant, also...
20-Sep-2024 10:05 AM EDT Add to Favorites

Â鶹´«Ã½: 66e98ef71906d_KenanOnelRoswellPark2024.jpeg

Inherited Changes in BRCA Genes Linked to Increased Risk of Multiple Myeloma

A significant number of multiple myeloma patients may have an inherited but previously unrecognized risk of developing the disease, a new study led by Roswell Park Chief of Clinical Genomics Kenan Onel, MD, PhD, reveals.
17-Sep-2024 10:05 AM EDT Add to Favorites

Â鶹´«Ã½: sabygeorgenewweb.jpg

Roswell Park-Designed Treatment Regimen Doubles Progression-Free Survival in Metastatic Kidney Cancer

During the European Society for Medical Oncology (ESMO) Congress, Saby George, MD, FACP, of Roswell Park Comprehensive Cancer Center presented findings on a novel two-agent treatment that more than doubled progression-free survival compared with...
15-Sep-2024 11:05 AM EDT Add to Favorites


See All News

Our Experts on News

Cancer-Specific Clinical Research Center: New Frontiers in Research at Roswell Park

Clinical trials are the frontier for targeted cancer drugs. Roswell Park Cancer Institute recently opened one of only a few clinical research centers in the U.S. focused exclusively on cancer. The Clinical Research Center, under the direction of...
4-Apr-2008 1:00 PM EDT

See All Experts

About

Roswell Park Comprehensive Cancer Center is a community united by the drive to eliminate cancer’s grip on humanity by unlocking its secrets through personalized approaches and unleashing the healing power of hope. Founded by Dr. Roswell Park in 1898, it is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. Learn more at www.roswellpark.org, or contact us at 1-800-ROSWELL (1-800-767-9355) or [email protected].

Experts

Twitter

close
0.34882